Ivermectin prescriptions spiked after Mel Gibson touted it for cancer on Joe Rogan’s podcast
There is no hard evidence that ivermectin can treat cancer, but that hasn’t stopped people from trying it
Dimas Ardian/Bloomberg via Getty Images
Ivermectin prescriptions skyrocketed in the six months after actor Mel Gibson claimed a version of the drug successfully treated three of his friends’ cancer on influencer Joe Rogan’s podcast, a new study found.
On a January 2025 episode of The Joe Rogan Experience, Gibson said that the antiparasitic drugs ivermectin and fenbendazole, which are both commonly used to treat worms in animals, had made his friends’ cancer disappear. Ivermectin, the development of which won two researchers part of the 2015 Nobel Prize in Physiology or Medicine, is well proven for its safety and effectiveness in treating diseases caused by parasitic worms in people. But there is no clinical trial evidence to suggest that either drug can treat cancer in humans, and fenbendazole isn’t approved for human use.
Animal studies suggest ivermectin and benzimidazole, a class of drugs that includes fenbendazole, may have certain properties that could inhibit tumor growth, but this use is unproven. In February the National Cancer Institute said it was investigating ivermectin’s ability to treat cancer, but the research is preclinical, meaning that whatever findings come of it still cannot be applied to patients without further studies.
On supporting science journalism
If you’re enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
Nevertheless, after Gibson’s endorsement, prescription rates for ivermectin and benzimidazole doubled from January 2025 to July 2025 compared with the same period in 2024, the study found. Prescriptions specifically for patients with cancer also rose precipitously—rates were 2.5 times higher last July than they were in January 2025, compared with the same period in 2024. Male patients and white patients, as well as patients living in the U.S. South, were also more likely to be prescribed the drug, according to the research.
Importantly, the study can’t definitively say that Gibson and Rogan’s conversation caused the spike in ivermectin prescriptions, and it’s unclear whether the patients who received ivermectin chose to use it over other established cancer therapies, such as chemotherapy and radiation.
Still, the results underscore a growing chorus of concern from clinicians and researchers over ivermectin’s off-label use. Prescriptions of the drug also surged during the early days of the COVID pandemic, when it was touted as a potential treatment for the disease based on preliminary positive findings that turned out to be false. Now some experts fear the same could happen with cancer.
“Our findings extend prior work on the potential influence of celebrity endorsement on health care utilization,” the study authors write. “Such influence gains traction when institutional trust erodes. Protecting vulnerable populations from misinformation-driven deviations from evidence-based care requires coordinated action by clinicians, health systems, researchers, and policymakers.”
It’s Time to Stand Up for Science
If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.
I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.
If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.
In return, you get essential news, captivating podcasts, brilliant infographics, can’t-miss newsletters, must-watch videos, challenging games, and the science world’s best writing and reporting. You can even gift someone a subscription.
There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.